acid-phosphatase and propionitrile

acid-phosphatase has been researched along with propionitrile* in 1 studies

Other Studies

1 other study(ies) available for acid-phosphatase and propionitrile

ArticleYear
The influence of cysteamine and propionitrile on duodenal phosphoprotein phosphatase in rats.
    Archives of biochemistry and biophysics, 1988, Aug-01, Volume: 264, Issue:2

    Cysteamine and propionitrile cause severe duodenal ulcers with perforation within 24-48 h after a single injection in rats. These animal models were used to gain insight into the early, preulcerogenic biochemical changes in the duodenal mucosa. The results indicate that a single sc injection of cysteamine and propionitrile induced dose- and time-dependent decreases in the activity of phosphoprotein phosphatase (PPPase) in homogenate and particulate fractions of rat duodenal mucosa. The decrease in enzyme activity was detectable 4 h after the injection of the ulcerogens, it was maximal at 12 h, and hardly detectable at 24 h. No effect on the enzyme activity was found under in vitro conditions. PPPase activity in the liver was not influenced by either cysteamine or propionitrile. Furthermore, the toxic but nonulcerogenic derivative of cysteamine ethanolamine had no effect on PPPase in the duodenum. Thus, the effect of the duodenal ulcerogens on PPPase activity was indirect and organ specific, related only to the target organ (i.e., duodenal mucosa). The effect of the drugs was also selective at the level of mucosal cells: both duodenal ulcerogens depleted protein and alkaline phosphatase but not lysosomal acid phosphatase. The decrease of PPPase activity could be a general property of the duodenal ulcerogens since it is independent of their effect on endogenous somatostatin.

    Topics: Acid Phosphatase; Alkaline Phosphatase; Animals; Cysteamine; Dose-Response Relationship, Drug; Duodenal Ulcer; Duodenum; Ethanolamine; Ethanolamines; Female; Intestinal Mucosa; Kinetics; Nitriles; Phosphoprotein Phosphatases; Rats; Rats, Inbred Strains; Somatostatin

1988